Imperial College London


Faculty of MedicineDepartment of Brain Sciences

Professor of Practice (Neurology)







12L12CLab BlockCharing Cross Campus





I work as part of the MS research team carrying out commercial and academic studies.  I am also involved in the biology of MS and novel imaging techniques.    



Garjani A, Middleton RM, Nicholas R, et al., 2022, Recovery From COVID-19 in Multiple Sclerosis: A Prospective and Longitudinal Cohort Study of the United Kingdom Multiple Sclerosis Register., Neurol Neuroimmunol Neuroinflamm, Vol:9

Simpson-Yap S, De Brouwer E, Kalincik T, et al., 2021, Associations of Disease-Modifying Therapies With COVID-19 Severity in Multiple Sclerosis, Neurology, Vol:97, ISSN:0028-3878, Pages:E1870-E1885

Middleton RM, Craig EM, Rodgers WJ, et al., 2021, COVID-19 in Multiple Sclerosis: Clinically reported outcomes from the UK Multiple Sclerosis Register, Multiple Sclerosis and Related Disorders, Vol:56, ISSN:2211-0348

Huang Y, Rodgers WJ, Middleton RM, et al., 2021, Willingness to receive a COVID-19 vaccine in people with multiple sclerosis - UK MS Register survey, Multiple Sclerosis and Related Disorders, Vol:55, ISSN:2211-0348

Rodgers WJ, Friede T, Vonberg FW, et al., 2021, The impact of smoking cessation on multiple sclerosis disease progression, Multiple Sclerosis Journal, Vol:27, ISSN:1352-4585, Pages:41-42

More Publications